Clinical Trial Update: A Multi-Center, Prospective, Observational Study of Patients Being Treated With ORGOVYX

View source ↗

Summary

A multi-center, prospective observational study of patients treated with ORGOVYX (relugolix) for prostate cancer; the study is currently active but not recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• ORGOVYX (RELUGOLIX)

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Prostate Cancer | Status: ACTIVE_NOT_RECRUITING